Properties
Description
QL47 is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Formula
C27H21N5O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
QL47 is a potent inhibitor of Bruton's tyrosine kinase (BTK), a key enzyme involved in B-cell receptor signaling. Its inhibition has significant implications for the treatment of autoimmune diseases and certain B-cell malignancies, such as lymphoma and leukemia.
